Our diabetes disaster looks at the idea that patients often don’t use the information they have to regulate their blood sugars, and a lot of times this is because the right information only makes things worse. Usually this has to do with insulin dosing, and for many patients it can have …

In part 1 of this Exclusive Interview, DIC Publisher Steve Freed talks with Dr. Andy Rhinehart to learn about a new insulin dosing support software that is used in conjunction with doctor intervention.

In this week's Homerun Slides, surprising information about SGLT-2 inhibitors.

Twin and family studies indicate that genetic factors alone cannot explain the etiology of T1DM. Seasonality, increasing incidence and epidemics of T1DM as well as numerous ecological, cross-sectional and retrospective studies suggest a critical role of environmental factors, such as infections with certain viruses (especially enteric infections in early life) and effects of early childhood diet. Natural history studies that follow children at increased risk of T1DM provide the best opportunity to study environmental triggers.

The 2016 professional cycling season has started, and this week Team NovoNordisk is competing in the Tour of Dubai. This race brings together professional cycling teams from all over the world and many of the top riders, including 4 former Tour de France winners. As you know, all the TNN …

How SGLT-2 inhibitors can provide new approach over treatment centered on attaining glycemic control, intensive therapy.

New management recommendations for the treatment of type 2 diabetes.

New study suggests possible role for DPP-4 inhibitor in reducing CVD risk.

Uncontrolled blood glucose seems to increase the risk of brain troubles.

Metformin, sulfonylureas, and insulin show varied survival rates in patients with type 2 diabetes.